Apetiz (Megestrol Acetate) tablet contains 160 mg of Megestrol Acetate which is a synthetic progestin.


Megestrol Acetate causes weight gain by increasing the fat and body cell mass, and this weight gain is associated with increased appetite. Therefore this drug is used as an appetite stimulant for cancer patients suffering from anorexia, significant weight loss or cachexia.


    Apetiz Tablet: Each film-coated tablet contains Megestrol Acetate USP 160 mg.


    Apetiz tablet is used for the treatment of Anorexia-cachexia syndrome in cancer patients.

Dosage & Administration

    Anorexia-cachexia syndrome: The recommended dose of Apetiz is 400 to 800 mg/day for at least two months and could be taken without regard to the meal.


    History of hypersensitivity to Megestrol Acetate or any component of the formulation and in case of known or suspected pregnancy.

Warning & Precautions

    History of thromboembolic disease. Monitor for signs/symptoms of adrenal insufficiency; consider empiric therapy if occurs. Diabetes, renal impairment, elderly, fetal toxicity, obtain (-) pregnancy test prior to initiation. Advise females of reproductive potential to use effective contraception during therapy and for nursing mothers it is not recommended.

Side effects

    Some common adverse events which occurred in at least 5% of patients are diarrhea, impotence, rash, flatulence, hypertension, asthenia, insomnia, nausea, anemia, fever, decreased libido, dyspepsia, hyperglycemia, headache, pain, vomiting, pneumonia & urinary frequency. Some other adverse events also occurred in 1% to 3% of all patients are abdominal pain, chest pain, infection, moniliasis and sarcoma, cardiomyopathy and palpitation, constipation, dry mouth, hepatomegaly, increased salivation and oral moniliasis, leukopenia, increased LDH, edema & peripheral edema, paresthesia, confusion, convulsion, depression, neuropathy, hyperesthesia & abnormal thinking, dyspnea, cough, pharyngitis & lung disorder, alopecia, herpes, pruritus, vesiculobullous rash, sweating and skin disorder, amblyopia, albuminuria, urinary incontinence, urinary tract infection and gynecomastia. A rarely encountered side effect of prolonged administration of Megestrol Acetate is urticaria.

    Serious side effects and what to do about them
    Symptom / effect Talk to your healthcare professional

    Stop taking

    drug and get immediate medical help

    Only if severe In all cases
    Edema (caused by excess fluid)    
    Very Rare
    Adrenal insufficiency (abdominal pain, nausea, vomiting, dizziness, weakness, fatigue, low blood pressure and kidney failure.)    
    Pulmonary embolism (sudden chest pain,
    shortness of breath, cough, fatigue, and heart palpitations)
    Tumor Flare (temporary worsening of tumor symptoms, such as pain, redness, or tumor size)    
    Vaginal bleeding    
    Carpal tunnel syndrome (numbness and tingling in the hand and arm)    
    Cushing's syndrome (round and red face, high blood pressure, abdomen obesity with thin arms and legs, red stretch marks, a fat lump between the shoulders, weak muscles, weak bones, acne, and fragile skin that heals poorly. Women may have more hair and irregular menstruation)    
    Dyspnea (difficulty breathing, shortness of breath)    
    Heart failure    
    High blood pressure    
    Loss of hearing    
    Osteoporosis/osteopenia (weak and brittle bones)    
    New or worsening diabetes or hyperglycemia (unusual thirst, hunger, frequent urination, fatigue,
    or weight gain or loss)
    Thrombophlebitis (inflammation of veins)    


Drug interaction

    Pharmacokinetic studies show that there is no significant alteration in pharmacokinetic parameters of Zidovudine or Rifabutin to warrant dosage
    adjustment when Megestrol Acetate is administered with these drugs.

Use in special groups

    Use in Pregnancy & Lactation: No adequate animal teratology information is available at clinically relevant doses. Because of the potential for adverse effects on the newborn, nursing should be discontinued if Megestrol Acetate is required.

    Use In Children & Adolescents (<18 Years Of Age): Safety and effectiveness in pediatric patients have not been established. Megestrol Acetate is not recommended for use in children.

    Geriatric Use (>65 Years Of Age)In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range.


    Apetiz Tablet: Store within 30°C. Protect from light.

    Apetiz Tablet:
    Each box contains 10 or 30 tablets in alu-alu blister pack.